Published in

F1000 - Post-publication peer review of the biomedical literature

DOI: 10.3410/f.727466628.793533799

Links

Tools

Export citation

Search in Google Scholar

Faculty of 1000 evaluation for Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial.

Dataset published in 2017 by Michael Mayr ORCID, Patrizia Amico
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.

Full text: Unavailable

Question mark in circle
Preprint: policy unknown
Upload
Question mark in circle
Postprint: policy unknown
Upload
Question mark in circle
Published version: policy unknown
Upload